Pharmaceutical/Biotech Companies
Whether determining the appropriate outcome metrics and standards for future access/reimbursement payer decisions or preparing for generic competition, ORM guides a pharmaceutical company's strategic choices in order to achieve their revenue goals. The majority of ORM's products and services are directed specifically at pharmaceutical companies.
Payers
ORM provides a perspective on the oncology marketplace that is often difficult for payers to acquire. A neutral point of view regarding the various key stakeholders can better inform some of the decisions payers must make. For specific initiatives, who are the prominent influencers? How and where do they exert their influence? How are they incentivized?
GPOs/Distributors
Using the GPO as a channel for promotion is often significantly underutilized by pharmaceutical companies. ORM facilitates the development of effective partnerships between distributors, their GPO membership, and pharmaceutical companies, such that it is a win/win situation for everyone. This can be achieved only when the approach to contracting aligns with a product's strategy, creating synergy among the various promotional initiatives within this channel.
Professional Associations
Professional associations play a critical role in aligning key oncology stakeholders at both the national and regional levels. ORM helps these organizations develop and implement strategies that not only achieve their goals for oncologists, but also support what is in the best interest of payers, pharmaceutical companies, and other oncology key players.
Oncologists
ORM does not provide reimbursement services for individual practices (coverage, coding, and billing). However, ORM does provide data, analyses, and recommendations to groups of practices that seek to improve how they work with other key stakeholders (pharmaceutical companies, payers, and distributors).